Mahmoud A Mohammad1, Inka C Didelija1, Barbara Stoll1, Juan C Marini1,2. 1. USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, USA. 2. Pediatric Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Abstract
BACKGROUND: The citrulline generation test (CGT) has been proposed as a tool to determine gut function. However, the increase in plasma citrulline concentration that follows a bolus dose of alanyl-glutamine may also result from a reduction in citrulline clearance due to competition with glutamine for transport. MATERIALS AND METHODS: A swine model was developed, and stable isotope tracers were used to determine the mechanism behind the increase in plasma citrulline that follows a bolus dose of alanyl-glutamine. Plasma concentrations and enrichments were determined, and a non-steady-state model was used to calculate rates of appearance, disappearance, and conversion. RESULTS: The pig model recapitulated the increase in plasma citrulline observed in humans after a dose of alanyl-glutamine. The dipeptide was rapidly hydrolyzed to its constitutive amino acids. Both citrulline plasma concentration and citrulline rate of appearance increased by ≈45% after the bolus dose of alanyl-glutamine. The conversion of citrulline to arginine and the rate of appearance of arginine also increased. Glutamine contributed up to 25% ± 2% of the rate of appearance of citrulline. No changes in the rate of disappearance of citrulline were observed. CONCLUSION: Our results indicate that a single bolus dose of alanyl-glutamine increases plasma citrulline concentration by increasing citrulline production without any effect on citrulline disposal. Our findings strongly indicate that the CGT assesses the metabolic response of the gut and that CGT can become a useful tool to evaluate gut mass and function.
BACKGROUND: The citrulline generation test (CGT) has been proposed as a tool to determine gut function. However, the increase in plasma citrulline concentration that follows a bolus dose of alanyl-glutamine may also result from a reduction in citrulline clearance due to competition with glutamine for transport. MATERIALS AND METHODS: A swine model was developed, and stable isotope tracers were used to determine the mechanism behind the increase in plasma citrulline that follows a bolus dose of alanyl-glutamine. Plasma concentrations and enrichments were determined, and a non-steady-state model was used to calculate rates of appearance, disappearance, and conversion. RESULTS: The pig model recapitulated the increase in plasma citrulline observed in humans after a dose of alanyl-glutamine. The dipeptide was rapidly hydrolyzed to its constitutive amino acids. Both citrulline plasma concentration and citrulline rate of appearance increased by ≈45% after the bolus dose of alanyl-glutamine. The conversion of citrulline to arginine and the rate of appearance of arginine also increased. Glutamine contributed up to 25% ± 2% of the rate of appearance of citrulline. No changes in the rate of disappearance of citrulline were observed. CONCLUSION: Our results indicate that a single bolus dose of alanyl-glutamine increases plasma citrulline concentration by increasing citrulline production without any effect on citrulline disposal. Our findings strongly indicate that the CGT assesses the metabolic response of the gut and that CGT can become a useful tool to evaluate gut mass and function.
Authors: Job H C Peters; Nicolette J Wierdsma; Tom Teerlink; Paul A M van Leeuwen; Chris J J Mulder; Ad A van Bodegraven Journal: Am J Gastroenterol Date: 2007-12 Impact factor: 10.864
Authors: Petra G Boelens; Gerdien C Melis; Paul A van Leeuwen; Gabrie A ten Have; Nicolaas E Deutz Journal: Am J Physiol Endocrinol Metab Date: 2006-05-09 Impact factor: 4.310
Authors: T Lau; W Owen; Y M Yu; N Noviski; J Lyons; D Zurakowski; R Tsay; A Ajami; V R Young; L Castillo Journal: J Clin Invest Date: 2000-05 Impact factor: 14.808
Authors: Erica P A Rutten; Marielle P K J Engelen; Emiel F M Wouters; Annemie M W J Schols; Nicolaas E P Deutz Journal: Am J Clin Nutr Date: 2006-01 Impact factor: 7.045
Authors: J H C Peters; N J Wierdsma; T Teerlink; P A M van Leeuwen; C J J Mulder; A A van Bodegraven Journal: Aliment Pharmacol Ther Date: 2008-03-10 Impact factor: 8.171
Authors: Marcel C G van de Poll; Gerdien C Ligthart-Melis; Petra G Boelens; Nicolaas E P Deutz; Paul A M van Leeuwen; Cornelis H C Dejong Journal: J Physiol Date: 2007-03-08 Impact factor: 5.182
Authors: Mahmoud A Mohammad; Inka C Didelija; Xioying Wang; Barbara Stoll; Douglas G Burrin; Juan C Marini Journal: Am J Physiol Renal Physiol Date: 2019-11-25